Genentech, Inc. (United States)

Genentech is a pioneering biotechnology company and member of the Roche Group, headquartered in South San Francisco. The company discovers and develops groundbreaking medicines for cancer, immunology, neuroscience, and infectious diseases. Key products include Herceptin, Avastin, and Perjeta for cancer, Rituxan for blood cancers and autoimmune diseases, Ocrevus for multiple sclerosis, and Actemra for rheumatoid arthritis. Genentech’s legacy of biotechnology innovation continues advancing treatments for serious diseases.